The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-17
DOI
10.3389/fimmu.2021.611256
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD - disease outcome and response to therapy
- (2021) Bram Verstockt et al. Journal of Crohns & Colitis
- P099 LEUKOCYTOCLASTIC VASCULITIS AFTER USTEKINUMAB INDUCTION IN CROHN'S DISEASE: A CASE SERIES AND SYSTEMATIC REVIEW
- (2020) Rishika Chugh et al. GASTROENTEROLOGY
- DOP65 Mirikizumab regulates genes involved in anti-TNF resistance and ulcerative colitis disease activity
- (2020) B Steere et al. Journal of Crohns & Colitis
- DOP56 Ustekinumab maintained clinically meaningful improvement in health-related quality of life in patients with moderate to severe ulcerative colitis: Results from the UNIFI long-term extension
- (2020) W J Sandborn et al. Journal of Crohns & Colitis
- P719 Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study
- (2020) A Amiot et al. Journal of Crohns & Colitis
- P687 Early and sustained improvement in stool frequency and rectal bleeding following 52 weeks of mirikizumab treatment
- (2020) G R D’Haens et al. Journal of Crohns & Colitis
- OP28 Gene expression (GE) values in a phase 2 trial of mirikizumab in ulcerative colitis (UC) correlate better with histopathology (HP) than endoscopy (EN) and Mayo scores
- (2020) B Steere et al. Journal of Crohns & Colitis
- P434 Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from Eneida Registry
- (2020) M Chaparro et al. Journal of Crohns & Colitis
- P565 Efficacy and safety of long-term treatment with ustekinumab in moderate–severe ulcerative colitis patients with delayed response to ustekinumab induction: Results from UNIFI 2-year long-term extension
- (2020) B E Sands et al. Journal of Crohns & Colitis
- P712 Association of histologic-endoscopic mucosal healing after ustekinumab induction or maintenance therapy with 2-year outcomes in the UNIFI Phase 3 study in ulcerative colitis
- (2020) K Li et al. Journal of Crohns & Colitis
- P633 Sustained reduction of IL-23-related cytokines IL-17A and IL-22 in a phase 2 study of mirikizumab in the treatment of patients with moderately-to-severely active ulcerative colitis through week 52
- (2020) G R D’Haens et al. Journal of Crohns & Colitis
- Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
- (2020) Christopher T Ritchlin et al. LANCET
- Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
- (2020) Désirée van der Heijde et al. ANNALS OF THE RHEUMATIC DISEASES
- Tu1849 HISTOLOGIC REMISSION AND MUCOSAL HEALING IN A PHASE 2 STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
- (2020) Rish Pai et al. GASTROENTEROLOGY
- Tu1887 IMPACT OF MIRIKIZUMAB TREATMENT ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A PHASE 2 STUDY ANALYSIS USING THE SF-36 V2 STANDARD
- (2020) Gary R. Lichtenstein et al. GASTROENTEROLOGY
- Tu1886 DOSE ADJUSTMENT IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE UNIFI MAINTENANCE STUDY LONG-TERM EXTENSION
- (2020) Bruce E. Sands et al. GASTROENTEROLOGY
- Sa1893 PRIOR IMMUNOGENICITY TO ANTI-TNF BIOLOGICS IS NOT ASSOCIATED WITH INCREASED ANTI-DRUG ANTIBODIES TO VEDOLIZUMAB OR USTEKINUMAB
- (2020) Nicholas J. Costable et al. GASTROENTEROLOGY
- Sa1827 PREGNANCY OUTCOMES IN WOMEN WITH PSORIASIS, PSORIATIC ARTHRITIS, CROHN'S DISEASE AND ULCERATIVE COLITIS TREATED WITH USTEKINUMAB
- (2020) Sheri Volger et al. GASTROENTEROLOGY
- Bimekizumab for patients with moderate-to-severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled phase 2b extension study
- (2020) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials
- (2020) Mark C Genovese et al. RHEUMATOLOGY
- S0872 Healthcare Cost Offsets From Reductions in Ulcerative Colitis-Related Hospitalizations and Surgeries in Patients Treated With Ustekinumab in the UNIFI Study
- (2020) Zhijie Ding et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- S2261 Combining Cyclosporine With Ustekinumab in Acute Severe Ulcerative Colitis: Report of 2 Cases
- (2020) Seth R. Shaffer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- S2269 Efficacy of Intravenous Ustekinumab as Induction Therapy for Patients Hospitalized With Severe Inflammatory Bowel Disease: A Case Series
- (2020) Alexander Hooper et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- S0779 Effect of Ustekinumab Maintenance Therapy on Stool Frequency and Rectal Bleeding Through 2 Years in the UNIFI Phase 3 Study in Ulcerative Colitis
- (2020) Maria T. Abreu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- S0682 Absence of Bowel Urgency Is Associated With Significantly Improved Inflammatory Bowel Disease Related Quality of Life in a Phase 2 Trial of Mirikizumab in Patients With Ulcerative Colitis
- (2020) Marla C. Dubinsky et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- S0683 Absence of Bowel Urgency Is Associated With Improvements in Clinical Outcomes in Patients With Ulcerative Colitis Receiving Mirikizumab
- (2020) Marla C. Dubinsky et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- S0845 Pharmacokinetics and Immunogenicity of Maintenance Therapy With Ustekinumab: 2-Year Results From the UNIFI Long-Term Extension Study
- (2020) Omoniyi Adedokun et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity
- (2019) María Martínez-López et al. IMMUNITY
- Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
- (2019) Stefan Schreiber et al. ANNALS OF THE RHEUMATIC DISEASES
- Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn’s Disease Patient: First Case Report and Literature Review
- (2019) Pedro Costa-Moreira et al. Journal of Crohns & Colitis
- Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
- (2019) Nai-Lun Yeh et al. CLINICAL DRUG INVESTIGATION
- Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
- (2019) William J. Sandborn et al. GASTROENTEROLOGY
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Can IL-23 be a good target for ulcerative colitis?
- (2018) Mariangela Allocca et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Anti-IL-23 receptor monoclonal antibody prevents CD4 + T cell-mediated colitis in association with decreased systemic Th1 and Th17 responses
- (2018) Emiko Imamura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling study
- (2018) Sanja Dragasevic et al. CLINICAL IMMUNOLOGY
- Incidence and risk of inflammatory bowel disease in patients with psoriasis – a nationwide 20-year cohort study
- (2018) Alexander Egeberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
- (2018) Tao Zuo et al. Frontiers in Microbiology
- Evaluation of interleukin 23 (IL-23) as a non-invasive test of disease severity in patients with ulcerative colitis
- (2018) Tarek Youssef et al. Arab Journal of Gastroenterology
- IL-23 in inflammatory bowel diseases and colon cancer
- (2018) Markus F. Neurath CYTOKINE & GROWTH FACTOR REVIEWS
- IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
- (2018) Alexander R. Moschen et al. Nature Reviews Gastroenterology & Hepatology
- Association of Psoriasis With Inflammatory Bowel Disease
- (2018) Yun Fu et al. JAMA Dermatology
- Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study
- (2017) Bruce E. Sands et al. GASTROENTEROLOGY
- Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab
- (2017) D Laharie et al. GUT
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
- (2017) Marcus Harbord et al. Journal of Crohns & Colitis
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
- (2017) Fernando Magro et al. Journal of Crohns & Colitis
- Meta-Analysis of Risk Association Between Interleukin-17A and F Gene Polymorphisms and Inflammatory Diseases
- (2017) Ebrahim Eskandari-Nasab et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Ulcerative colitis
- (2017) Ryan Ungaro et al. LANCET
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL23R single nucleotide polymorphisms could be either beneficial or harmful in ulcerative colitis
- (2017) Sarah Fischer et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation
- (2016) Pawan Kumar et al. IMMUNITY
- mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production
- (2016) Feidi Chen et al. JOURNAL OF IMMUNOLOGY
- IL-17 in Chronic Inflammation: From Discovery to Targeting
- (2016) Audrey Beringer et al. TRENDS IN MOLECULAR MEDICINE
- IL-23R mutation is associated with ulcerative colitis: A systemic review and meta-analysis
- (2016) Ling-Long Peng et al. Oncotarget
- CD11c+ monocyte/macrophages promote chronic Helicobacter hepaticus-induced intestinal inflammation through the production of IL-23
- (2015) I C Arnold et al. Mucosal Immunology
- The IL-23–IL-17 axis in inflammatory arthritis
- (2015) Erik Lubberts Nature Reviews Rheumatology
- Biological Agents for Moderately to Severely Active Ulcerative Colitis
- (2014) Silvio Danese et al. ANNALS OF INTERNAL MEDICINE
- The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study
- (2014) Carmen Stolwijk et al. ANNALS OF THE RHEUMATIC DISEASES
- Role of the Microbiota in Immunity and Inflammation
- (2014) Yasmine Belkaid et al. CELL
- Involvement of IL-23 in enteropathic arthritis patients with inflammatory bowel disease: preliminary results
- (2014) Tamer A. Gheita et al. CLINICAL RHEUMATOLOGY
- Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: A meta-analysis
- (2014) Juan Li WORLD JOURNAL OF GASTROENTEROLOGY
- Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation
- (2013) M Zaeem Cader et al. GUT
- Genetic polymorphisms of interleukin 17A and interleukin 17F and their association with inflammatory bowel disease in a Chinese Han population
- (2013) Xiaofei Zhang et al. INFLAMMATION RESEARCH
- Serum IL-17A in Newly Diagnosed Treatment-Naive Patients with Ulcerative Colitis Reflects Clinical Disease Severity and Predicts the Course of Disease
- (2013) Lena Öhman et al. INFLAMMATORY BOWEL DISEASES
- IL-23/IL-17A Axis Correlates with the Nitric Oxide Pathway in Inflammatory Bowel Disease: Immunomodulatory Effect of Retinoic Acid
- (2013) Hayet Rafa et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis
- (2012) Ranji Hayashi et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Differential Interleukin-10 (IL-10) and IL-23 Production by Human Blood Monocytes and Dendritic Cells in Response to Commensal Enteric Bacteria
- (2012) Jennifer Manuzak et al. Clinical and Vaccine Immunology
- Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
- (2012) Marte Lie Høivik et al. GUT
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Cutting Edge: Regulation of Intestinal Inflammation and Barrier Function by IL-17C
- (2012) Joseph M. Reynolds et al. JOURNAL OF IMMUNOLOGY
- Toll-Like Receptor 5 Engagement Induces Interleukin-17C Expression in Intestinal Epithelial Cells
- (2012) Eunok Im et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Epidemiology and Natural History of Inflammatory Bowel Diseases
- (2011) Jacques Cosnes et al. GASTROENTEROLOGY
- Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease
- (2011) S. W. Kim et al. GUT
- Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
- (2011) Joana Torres et al. INFLAMMATORY BOWEL DISEASES
- Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts
- (2011) Fernando Magro et al. INFLAMMATORY BOWEL DISEASES
- Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice
- (2011) J H Cox et al. Mucosal Immunology
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
- The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease
- (2010) T. Sugihara et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
- (2009) Ivaylo I. Ivanov et al. CELL
- Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
- (2009) Harumichi Ishigame et al. IMMUNITY
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A protective function for interleukin 17A in T cell–mediated intestinal inflammation
- (2009) William O'Connor Jr et al. NATURE IMMUNOLOGY
- Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine
- (2008) Ivaylo I. Ivanov et al. Cell Host & Microbe
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
- RORγ-Expressing Th17 Cells Induce Murine Chronic Intestinal Inflammation via Redundant Effects of IL-17A and IL-17F
- (2008) Moritz Leppkes et al. GASTROENTEROLOGY
- Regulation of inflammatory responses by IL-17F
- (2008) Xuexian O. Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells
- (2008) Franca Gerosa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-23 and Th17 cytokines in intestinal homeostasis
- (2008) K J Maloy et al. Mucosal Immunology
- A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
- (2008) Ken Cadwell et al. NATURE
- RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22–producing NKp46+ cells
- (2008) Stephanie L Sanos et al. NATURE IMMUNOLOGY
- Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBD
- (2007) Julia Seiderer et al. INFLAMMATORY BOWEL DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started